“High Protection of COVID-19 Vaccine against Severe Disease during Delta and Omicron Periods in Japan”

https://pubmed.ncbi.nlm.nih.gov/38114409

The COVID-19 vaccine provides high protection against severe disease during both the Delta and early Omicron (BA.1/BA.2) periods in Japan, with three doses offering better protection during Omicron.